Lv21
150 积分 2025-02-23 加入
Impact of Patient Selection on Real-World Outcomes by Using the EMBRACE-II Treatment Protocol in Locally Advanced Cervical Cancer
15天前
已关闭
Patient-Derived Ovarian Cancer Organoids as Platforms for Predicting Platinum Resistance and Screening Tumor Stem Cell Inhibitors
23天前
已完结
Enhancing immunotherapy with tumour-responsive nanomaterials
1个月前
已完结
Overcoming therapeutic resistance in oncology: The prospects of inorganic nanotheranostics
1个月前
已关闭
Immunity‐Modulating Metal‐Based Nanomaterials for Cancer Immunotherapy
2个月前
已完结
Mechanisms of Ovarian Cancer-Associated Cachexia
2个月前
已完结
Mir-338-3p Increases the Sensitivity to Oxaliplatin via Reversing EpithelialmesenchymalTransition in Hepatocellular Carcinoma Cells
2个月前
已完结
MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells
2个月前
已完结
Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors
2个月前
已完结
YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy
2个月前
已完结
皖公网安备34019202002308
